Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

A new study suggests that women using menopause hormone therapy alongside GLP-1 medications like Wegovy may experience greater weight loss.

The Grammy winner wrote her 2025 song “The Mirror” about body dysmorphia and feeling comfortable in your own skin ...

Medifast, Inc. reported earnings results for the third quarter and nine months ended September 30, 2026. For the third quarter, the company reported sales was USD 72.05 million compared to USD 89.41 ...

Medifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management sa ...

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster ...

Medifast, Inc. provided earnings guidance for the fourth quarter and full year of 2026. For the quarter, the company expects fourth quarter 2026 revenue to be in the range of $55 million to ...

Petrelintide, an amylin agonist medication, may support weight loss with fewer gastrointestinal side effects than GLP-1 drugs, according to early research.

The Menopause Society noted that middle-aged women commonly experience weight gain resulting from menopause, and have turned to GLP-1 drugs for help. About 1 in 5 women 50 to 64 are or have used a GLP ...

GLP-1 drugs like Novo Nordisk's Ozempic and Wegovy rank among the biggest medical breakthroughs in years, owing to their efficacy in treating obesity and type ‌2 diabetes, and reducing the risk of ...

As a registered dietitian who helps busy parents lose weight — and as a mom of three myself — I know the struggle of trying to make just one dinner that works for everyone at the table. In many cases, ...

Ro's Body Program is a comprehensive weight loss solution that offers personalized plans utilizing a glucagon-like peptide-1 (GLP-1) receptor agonist medications such as Ozempic, Wegovy and Zepbound.